EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dmitrieva, R. I.
Right arrow Articles by Doris, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dmitrieva, R. I.
Right arrow Articles by Doris, P. A.
Experimental Biology and Medicine 227:561-569 (2002)
© 2002 Society for Experimental Biology and Medicine


MINIREVIEW

Cardiotonic Steroids: Potential Endogenous Sodium Pump Ligands with Diverse Function1

Renata I. Dmitrieva and Peter A. Doris,2

Institute of Molecular Medicine, University of Texas, Houston, Texas 77030

The highly conserved cardiotonic steroid (CS) binding site present on the ubiquitous membrane sodium pump, sodium, potassium-ATPase, appears to have been conserved by no force other than its capacity to bind CS: a family that includes plant-derived cardiac glycosides and putative endogenous vertebrate counterparts. Binding of ligand is inhibited by increased extracellular potassium. This implies functional coordination because inhibition of the sodium pump would be counterproductive when extracellular potassium is elevated. The interesting biology of the CS binding site continues to stimulate investigations into the identity of endogenous ligands, their role as pump regulators at the cellular level, and as mediators of body fluid balance and blood pressure regulation. In addition to inhibition of sodium and potassium transport, there is considerable recent evidence suggesting that the sodium pump may act as a cell signaling receptor activated by CS binding and responding by coordination of intracellular signaling pathways that can be dependent on and also independent of the reduction in transmembrane ion flux resulting directly from pump inhibition. This signaling may influence cell survival, growth, and differentiation. Recent insight into the biology of pump regulation by CS is reviewed.

Key Words: cardiotonic steroids • steroidogenesis • sodium balance • blood pressure • adrenal cortex • signal transduction • cancer




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. N. Orlov and A. A. Mongin
Salt-sensing mechanisms in blood pressure regulation and hypertension
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2039 - H2053.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Mijatovic, A. Op De Beeck, E. Van Quaquebeke, J. Dewelle, F. Darro, Y. de Launoit, and R. Kiss
The cardenolide UNBS1450 is able to deactivate nuclear factor {kappa}B-mediated cytoprotective effects in human non-small cell lung cancer cells.
Mol. Cancer Ther., February 1, 2006; 5(2): 391 - 399.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Langenhan, N. R. Peters, I. A. Guzei, F. M. Hoffmann, and J. S. Thorson
Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization
PNAS, August 30, 2005; 102(35): 12305 - 12310.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. A. Akimova, A. Y. Bagrov, O. D. Lopina, A. V. Kamernitsky, J. Tremblay, P. Hamet, and S. N. Orlov
Cardiotonic Steroids Differentially Affect Intracellular Na+ and [Na+]i/[K+]i-independent Signaling in C7-MDCK Cells
J. Biol. Chem., January 7, 2005; 280(1): 832 - 839.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Liu, J. Abramowitz, A. Askari, and J. C. Allen
Role of caveolae in ouabain-induced proliferation of cultured vascular smooth muscle cells of the synthetic phenotype
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2173 - H2182.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. M.A.M. Qazzaz, Z. Cao, D. D. Bolanowski, B. J. Clark, and R. Valdes Jr
De Novo Biosynthesis and Radiolabeling of Mammalian Digitalis-Like Factors
Clin. Chem., March 1, 2004; 50(3): 612 - 620.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Abramowitz, C. Dai, K. K. Hirschi, R. I. Dmitrieva, P. A. Doris, L. Liu, and J. C. Allen
Ouabain- and Marinobufagenin-Induced Proliferation of Human Umbilical Vein Smooth Muscle Cells and a Rat Vascular Smooth Muscle Cell Line, A7r5
Circulation, December 16, 2003; 108(24): 3048 - 3053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. I. Dmitrieva and P. A. Doris
Ouabain Is a Potent Promoter of Growth and Activator of ERK1/2 in Ouabain-resistant Rat Renal Epithelial Cells
J. Biol. Chem., July 18, 2003; 278(30): 28160 - 28166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
Z. Xie and T. Cai
Na+-K+-ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function
Mol. Interv., May 1, 2003; 3(3): 157 - 168.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. C. ALLEN, J. ABRAMOWITZ, and A. KOKSOY
Low Concentrations of Ouabain Activate Vascular Smooth Muscle Cell Proliferation
Ann. N.Y. Acad. Sci., April 1, 2003; 986(1): 504 - 508.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Experimental Biology and Medicine.